Exact Mass: 634.1839
Exact Mass Matches: 634.1839
Found 93 metabolites which its exact mass value is equals to given mass value 634.1839,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Novobiocin sodium
Novobiocin (Albamycin) sodium is a potent and orally active antibiotic. Novobiocin sodium also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin sodium has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin sodium shows anti-orthopoxvirus activity. An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) Novobiocin sodium. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1476-53-5 (retrieved 2024-10-09) (CAS RN: 1476-53-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Lactodifucotetraose
Lactodifucotetraose (LDFT) is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Lactodifucotetraose decreased substantially until day 5 in human milk and appeared to stabilize in the following days. (PMID: 15343178, 17375110, 2246719). Lactodifucotetraose is a normal blood-group-active oligosaccharide excreted as a component of the urine in type O (H) secretors. (PMID 510288). Lactodifucotetraose (LDFT) is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Lactodifucotetraose decreased substantially until day 5 in human milk and appeared to stabilize in the following days. (PMID: 15343178, 17375110, 2246719)
Haematin
Linarin monoacetate
6-O-(E)-p-coumaroyl-beta-D-fructofuranosyl-(2->1)-(6-O-(E)-p-coumaroyl-alpha-D-glucopyranoside
6,6-sucrose ester of (1alpha,2alpha,3beta,4beta)-3,4-bis(4-hydroxyphenyl)-1,2-cyclobutanedicarboxylic acid
4-hydroxy-phenylpropenyl-alpha-L-rhamnopyranosyl-(1->3)-4-O-feruloyl-beta-D-glucopyranoside
4-[6-O-(5-O-(3,4-dimethoxybenzoyl)-beta-apiofuranosyl)-beta-glucopyranoside]-5-methylcoumarin
1,8,9,10-tetrahydroxy-6H-naphtho[1,2-b]benzo[d]pyran-6-one-12-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside|jugnaphthalenoside B
1,2-methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-alpha-L-rhamnopyranosyl(1->2)-beta-D-(6-acetyl)-glucopyranoside
O3-alpha-L-Fucopyranosyl-O4-(O2-alpha-L-fucopyranosyl-beta-D-galactopyranosyl)-D-glucose
2-[3,5-di-O-beta-D-glu-4-(3-methylbut-2-enyl)phenyl]benzofuran-6-ol|2-[3,5-di-O-beta-D-glucosyl-4-(3-methylbut-2-enyl)phenyl]benzofuran-6-ol
Lactodifucotetraose
TRIPHENYLOLMETHANE TRIGLYCIDYL ETHER 2,6-TOLYLENE DIISOCYANATE ADDUCT
Berotralstat Hydrochloride
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Novobiocin sodium
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Novobiocin (Albamycin) sodium is a potent and orally active antibiotic. Novobiocin sodium also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin sodium has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin sodium shows anti-orthopoxvirus activity[1][2][3][4]. Novobiocin (Albamycin) sodium is a potent and orally active antibiotic. Novobiocin sodium also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin sodium has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin sodium shows anti-orthopoxvirus activity[1][2][3][4].
alpha-D-xylopyranosyl-(1->3)-beta-D-glucopyranuronosyl-(1->3)-alpha-D-xylopyranosyl-(1->3)-beta-D-glucopyranuronic acid
1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-2-[[(2-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
cis-Heme D hydroxychlorin gamma-spirolactone
A metallochlorin that is heme d in which the hydroxy group and the carboxy group of the 6-carboxyethyl substituent have undergone intramolecular condensation to afford the corresponding gamma-spirolactone.
4,5,18,19,20-pentahydroxy-3-(hydroxymethyl)-11,12-bis(4-hydroxyphenyl)-2,8,15,21,22-pentaoxatetracyclo[15.3.1.1³,⁶.0¹⁰,¹³]docosane-9,14-dione
(1r,2s,3s,4r,7s,8r,9r,10r,11r,13s,14r,17r)-2,7,9-tris(acetyloxy)-13-chloro-4-(chloromethyl)-4-hydroxy-8,17-dimethyl-12-methylidene-16-oxo-15,18-dioxatetracyclo[9.6.1.0¹,¹⁴.0³,⁸]octadecan-10-yl acetate
6-acetyl-5-hydroxy-2-(4-methoxyphenyl)-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-4-one
6,6'-sucrose ester of(1α,2α,3β,4β)-3,4-bis(4-hy-droxyphenyl)-1,2-cyclobutanedicarboxylicacid
{"Ingredient_id": "HBIN012044","Ingredient_name": "6,6'-sucrose ester of(1\u03b1,2\u03b1,3\u03b2,4\u03b2)-3,4-bis(4-hy-droxyphenyl)-1,2-cyclobutanedicarboxylicacid","Alias": "NA","Ingredient_formula": "C30H34O15","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "20431","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(6-o-(e)-p-coumaroyl)-β-d?fructofuranosyl-(2→1)-(6-o-(e)-p-coumaroyl)-α-d-gluco-pyranoside
{"Ingredient_id": "HBIN012670","Ingredient_name": "(6-o-(e)-p-coumaroyl)-\u03b2-d?fructofuranosyl-(2\u21921)-(6-o-(e)-p-coumaroyl)-\u03b1-d-gluco-pyranoside","Alias": "NA","Ingredient_formula": "C30H34O15","Ingredient_Smile": "C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3(C(C(C(O3)COC(=O)C=CC4=CC=C(C=C4)O)O)O)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
